I have a couple of things.
You talked a bit about how a treatment plan that included medical marijuana wouldn't be part of an acceptable treatment, from your perspective. When you started to look at PTSD more than in the past—as we all did—the corporation must have had to start to be more open to different or alternative therapies. I wondered if you want to comment on the processes inside the organization when you start to look at something like this that's—I'm going to use air quotes here—“new”. We know it isn't new, but it is new for institutions, governments, and insurance companies to look at PTSD and its effects on folks.